Patents by Inventor Jan Pierce

Jan Pierce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compositions
    Patent number: 11426433
    Abstract: A therapeutic composition can include an amount of amniotic fluid having a therapeutically effective amount of at least one protein, hyaluronic acid, or both. The therapeutic composition can be substantially free of lanugo, vernix, and cells harvested with the amniotic fluid.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: August 30, 2022
    Assignee: University of Utah Research Foundation
    Inventors: Jo-Anna Reems, Jan Pierce
  • THERAPEUTIC COMPOSITIONS
    Publication number: 20200268806
    Abstract: A therapeutic composition can include an amount of amniotic fluid having a therapeutically effective amount of at least one protein, hyaluronic acid, or both. The therapeutic composition can be substantially free of lanugo, vernix, and cells harvested with the amniotic fluid.
    Type: Application
    Filed: February 11, 2020
    Publication date: August 27, 2020
    Applicant: University of Utah Research Foundation
    Inventors: Jo-Anna Reems, Jan Pierce
  • Therapeutic compositions
    Patent number: 10555973
    Abstract: A therapeutic composition can include an amount of amniotic fluid having a therapeutically effective amount of at least one protein, hyaluronic acid, or both. The therapeutic composition can be substantially free of lanugo, vernix, and cells harvested with the amniotic fluid.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: February 11, 2020
    Assignee: University of Utah Research Foundation
    Inventors: Jo-Anna Reems, Jan Pierce
  • THERAPEUTIC COMPOSITIONS
    Publication number: 20180250343
    Abstract: A therapeutic composition can include an amount of amniotic fluid having a therapeutically effective amount of at least one protein, hyaluronic acid, or both. The therapeutic composition can be substantially free of lanugo, vernix, and cells harvested with the amniotic fluid.
    Type: Application
    Filed: March 6, 2017
    Publication date: September 6, 2018
    Applicant: University of Utah Research Foundation
    Inventors: Jo-Anna Reems, Jan Pierce